Gilead Sciences, Inc.
Marktkapitalisierung
$163.0B
Globaler Rang
#109
Allzeithoch
$163.0B
2026-07-02
Gesamtwachstum
+0%
seit 2026
Über Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) is a United States-based company in the Drug Manufacturers - General industry, part of the Healthcare sector. With a current market capitalization of $163.0B, it is ranked #109 among the world's largest companies. Its market cap peaked at $163.0B and reached as high as rank #109 in 2026.
Verlauf der Marktkapitalisierung von Gilead Sciences, Inc. (2026–2026)
Gilead Sciences, Inc. vergleichen
Rangverlauf
| Jahr | Marktkapitalisierung | Rang | Veränderung ggü. Vorjahr |
|---|---|---|---|
| 2026 | $163.0B | #109(↓1) | +8.3% |
| 2025 | $150.5B | #108(↑14) | +36.8% |
| 2024 | $110.0B | #122 | +18.8% |
| 2023 | $92.6B | #122(↓21) | -2.1% |
| 2022 | $94.6B | #101(↑27) | +23.9% |
| 2021 | $76.4B | #128(↑19) | +30.1% |
| 2020 | $58.7B | #147(↓39) | -6.9% |
| 2019 | $63.0B | #108(↓21) | +7.8% |
| 2018 | $58.5B | #87(↓7) | -10.1% |
| 2017 | $65.0B | #80(↓17) | +2.9% |
| 2016 | $63.2B | #63(↓27) | -27.7% |
| 2015 | $87.4B | #36(↑5) | +8.2% |
| 2014 | $80.8B | #41(↑6) | +25.5% |
| 2013 | $64.4B | #47(↑34) | +104.5% |
| 2012 | $31.5B | #81(↑39) | +79.5% |
| 2011 | $17.6B | #120(↑23) | +12.9% |
| 2010 | $15.5B | #143(↓33) | -16.2% |
| 2009 | $18.6B | #110(↓48) | -15.4% |
| 2008 | $21.9B | #62(↑50) | +11.1% |
| 2007 | $19.7B | #112(↑29) | +41.7% |
| 2006 | $13.9B | #141(↓3) | +23.5% |
| 2005 | $11.3B | #138(↑21) | +50.2% |
| 2004 | $7.5B | #159(↓4) | +20.1% |
| 2003 | $6.2B | #155(↑13) | +71.4% |
| 2002 | $3.6B | #168(↑20) | +3.5% |
| 2001 | $3.5B | #188(↑5) | +58.5% |
| 2000 | $2.2B | #193(↓23) | +53.2% |
| 1999 | $1.5B | #170(↓9) | +31.8% |
| 1998 | $1.1B | #161(↓5) | +7.4% |
| 1997 | $1.0B | #156 | +53.0% |
| 1996 | $670.1M | #156(↓18) | -21.9% |
| 1995 | $857.7M | #138(↓4) | +236.8% |
| 1994 | $254.6M | #134 |
Weitere Unternehmen im Sektor Gesundheitswesen
FAQ
What is Gilead Sciences, Inc.'s market cap?
Gilead Sciences, Inc. (GILD) has a market capitalization of $163.0B, making it the #109 largest company in the world by market cap.
What was Gilead Sciences, Inc.'s highest market cap?
Gilead Sciences, Inc.'s all-time high market cap was $163.0B, reached in 2026-07-02. Its highest rank was #109 in 2026.
What sector is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Gilead Sciences, Inc.'s market cap changed over time?
Gilead Sciences, Inc. has been tracked since 2026. Its market cap has grown by 0% from $163.0B in 2026 to $163.0B today.